These stocks don't match the qualities Buffett typically looks for in an investment.
News & Analysis: Johnson & Johnson
This decision hit Trump right in the pocketbook.
Some of the biggest companies on earth are giving their investors a share of the profits each quarter through dividends.
Investors need to be careful about which pharmaceutical stocks they own.
It’s rejected a pair of drugs in the last six months.
Coke's dividend is sweet, but these two stocks offer comparable yields and better long-term prospects.
The fine issued to the company last week was the first of its kind relating to the opioid crisis, and its effects could be far-reaching.
These income stocks are phased by virtually nothing, making them incredibly safe bets to deliver over the long run.
How much Johnson & Johnson will actually benefit is unclear.
It hasn't been a winning night for either company, although the scope of their losses is somewhat in question.